Sterling on track for worst week since September 2020

(Updates lede, updates prices)

LONDON, Aug 19 (Reuters) - The British pound is set to record its worst weekly loss versus the dollar since September 2020, as investors worried about economic slowdown flock to the U.S safe-haven currency.

By 1225 GMT the pound was down 0.9% against the dollar at $1.183 pence GBP=D3 - its lowest level in a month - while the dollar was on track for its best weekly performance in more than two years.

A surprise uptick in July UK retail sales failed to lift sterling, as soaring British inflation and recession risks continue to dominate traders' minds.

The retail sales data was offset by separate data showing UK consumer sentiment plummeted to a record low in August.

Markets remain focused on data out earlier this week showing inflation at the highest level in 40 years, which ramped up fears of an economic slowdown and increased pressure on the Bank of England (BoE) to bring down prices.

Those concerns are the main factor weighing on sterling this week, according to Simon Harvey head of FX analysis at Monex Europe.

"The clouds are forming and the outlook is definitely becoming a bit gloomier and that’s what’s being reflected in the price, irrespective of the retail sales," said Harvey.

Sterling was also 0.48% weaker versus the euro, trading at 84.950 pence EURGBP=D3 .

"We’ve seen underperformance in gilts, higher pricing of inflation in inflation swaps, more hawkish pricing from the Bank of England expected by money markets, and this has all exacerbated the expected recession that’s on the horizon for the UK."

Money markets are now fully pricing in another 50 basis point rate rise from the central bank next month, according to data from Refinitiv.

Graphic: World FX rates in 2022 Link
Graphic: Trade-weighted sterling since Brexit vote Link

Reporting by Lucy Raitano; Editing by Kim Coghill and Susan

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.